Providing custom tailored, high quality preclinical services to prime your drugs for success.
We offer expert solutions for optimal preclinical testing
- standardized efficacy evaluation platforms
- long standing expertise in preclinical testing
- humanized precision models
- unique animal models mimicking the complexity of human disease
- over 100 therapeutics successfully tested
- scientific excellence
Our agent in Korea
LATEST NEWS & BLOG
Apply now to receive free secondary phenotyping screening services from Biomedcode in the frame of INFRAFRONTIER2020 project
Biomedcode's R&D projects were presented in posters and talks and discussed with BSRC Al. Fleming scientists.
Biomedcode successfully participated in the EU Gateway organized Health Care and Medical Technologies Mission to Korea (March 12-14 2019).
PRECLINICAL SERVICES DELIVERED
OUR CLIENTS SAY
"Our company had a pleasant experience of productive collaboration with Biomedcode s.a. in 2015. We would like to especially highlight the high quality of the study protocol preparation and report writing as well as efficient communication with Biomedcode’s CEO. We greatly appreciate your professionalism and looking forward to our future collaboration."
"We have several collaborations with Biomedcode, their scientific and efficient experiment schedules made each collaboration accomplished according to plan. From Biomedcode, we obtained convincing study reports and detailed records, which saved a lot of time for us in whole pre-clinical stage. We believe contracting professional works to such a professional and sophisticated group is a wise choice."
"It was a great pleasure working with Biomedcode that exhibited great expertise in preclinical testing and handled all the steps of the study with great professionalism always abiding by the terms of the agreement and always staying in close communication with us making this a very productive collaboration."
Our PLOS Computational Biology paper presents a new analytical approach that can serve as powerful tool to evaluate and compare arthritis treatments
Biomedcode scientists coauthor a publication in Annals of Rheumatic diseases showing that Tg197 mice develop heart valve pathology sharing common...
Biomedcode scientists coauthor a publication in JCI insight showing that TNFΔARE mice develop mesenchymal cell dependent heart valve pathology with...